A Novel Method to Measure HLA-DM-susceptibility of Peptides Bound to MHC Class II Molecules Based on Peptide Binding Competition Assay and Differential IC(50) Determination
Overview
Pathology
Authors
Affiliations
HLA-DM (DM) functions as a peptide editor that mediates the exchange of peptides loaded onto MHCII molecules by accelerating peptide dissociation and association kinetics. The relative DM-susceptibility of peptides bound to MHCII molecules correlates with antigen presentation and immunodominance hierarchy, and measurement of DM-susceptibility has been a key effort in this field. Current assays of DM-susceptibility, based on differential peptide dissociation rates measured for individually labeled peptides over a long time base, are difficult and cumbersome. Here, we present a novel method to measure DM-susceptibility based on peptide binding competition assays performed in the presence and absence of DM, reported as a delta-IC(50) (change in 50% inhibition concentration) value. We simulated binding competition reactions of peptides with various intrinsic and DM-catalyzed kinetic parameters and found that under a wide range of conditions the delta-IC(50) value is highly correlated with DM-susceptibility as measured in off-rate assay. We confirmed experimentally that DM-susceptibility measured by delta-IC(50) is comparable to that measured by traditional off-rate assay for peptides with known DM-susceptibility hierarchy. The major advantage of this method is that it allows simple, fast and high throughput measurement of DM-susceptibility for a large set of unlabeled peptides in studies of the mechanism of DM action and for identification of CD4+ T cell epitopes.
Developability considerations for bispecific and multispecific antibodies.
Amash A, Volkers G, Farber P, Griffin D, Davison K, Goodman A MAbs. 2024; 16(1):2394229.
PMID: 39189686 PMC: 11352713. DOI: 10.1080/19420862.2024.2394229.
Baumgaertner P, Schmidt J, Costa-Nunes C, Bordry N, Guillaume P, Luescher I Front Immunol. 2022; 13:973986.
PMID: 36032094 PMC: 9399405. DOI: 10.3389/fimmu.2022.973986.
Impact of HLA-DR Antigen Binding Cleft Rigidity on T Cell Recognition.
Szeto C, Bloom J, Sloane H, Lobos C, Fodor J, Jayasinghe D Int J Mol Sci. 2020; 21(19).
PMID: 32992915 PMC: 7582474. DOI: 10.3390/ijms21197081.
A Missing Switch in Peptide Exchange for MHC Class II Molecules.
Freund C, Hofer T Front Immunol. 2019; 10:2513.
PMID: 31708929 PMC: 6820466. DOI: 10.3389/fimmu.2019.02513.
HLA-DO Modulates the Diversity of the MHC-II Self-peptidome.
Nanaware P, Jurewicz M, Leszyk J, Shaffer S, Stern L Mol Cell Proteomics. 2018; 18(3):490-503.
PMID: 30573663 PMC: 6398211. DOI: 10.1074/mcp.RA118.000956.